ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury

New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™EINDHOVEN, the Netherlands, May 15, 2023 -- ONWARD Medical N.V. , the medical technology company creating... | May 15, 2023

Related Keywords

Switzerland ,Massachusetts ,United States ,Netherlands ,Boston ,Swiss ,Aditi Roy ,Lara Smith Weber ,Lausanne University Hospital ,University Of Calgary ,Company Enquiries ,Swiss Federal Institute Of Technology Lausanne ,Vp Communications ,Engineering Center ,Centre Hospitalier Universitaire Vaudois ,Swiss Federal Institute Of Technology ,Jocelyne Bloch ,Swiss Federal Institute ,Technology Lausanne ,Device Designation ,Dave Marver ,Breakthrough Device Designations ,Media Enquiries ,Investor Enquiries ,Smith Weber ,Onward Medicalnv Stock Exchange ,News ,Information ,Press Release ,Few ,Head ,Us ,O ,Optimize ,The ,Delivery ,F ,Wonward ,Parc ,Bay ,023 ,Medical ,Technology ,Ompany Onwd Nl0015000ht4 ,